118 related articles for article (PubMed ID: 8740293)
21. Administration of growth hormone or IGF-I to pregnant rats on a reduced diet throughout pregnancy does not prevent fetal intrauterine growth retardation and elevated blood pressure in adult offspring.
Woodall SM; Breier BH; Johnston BM; Bassett NS; Barnard R; Gluckman PD
J Endocrinol; 1999 Oct; 163(1):69-77. PubMed ID: 10495409
[TBL] [Abstract][Full Text] [Related]
22. Wiedemann-Rautenstrauch syndrome prenatal diagnosis.
Becerra CH; Contreras-García GA; Perez Vera LA; Díaz-Martínez LA; Beltran Avendaño MA; Salazar Martínez HA
J Perinatol; 2014 Dec; 34(12):954-6. PubMed ID: 25421132
[No Abstract] [Full Text] [Related]
23. Impact of transient period of metabolic adaptation on perinatal asphyxia in neonates with intrauterine growth retardation.
Lazic Mitrovic T; Mikovic Z; Mandic Markovic V; Mihailovic S
J Matern Fetal Neonatal Med; 2017 Nov; 30(22):2665-2670. PubMed ID: 27838948
[TBL] [Abstract][Full Text] [Related]
24. GH treatment induces sustained catch-up growth in children with intrauterine growth retardation: 7-year results.
Albanese A; Stanhope R
Horm Res; 1997; 48(4):173-7. PubMed ID: 9378463
[TBL] [Abstract][Full Text] [Related]
25. [The effect of prenatal infusion of glucose on saccharide metabolism in the fetus and neonate].
Sabata V; Pribylová H
Cesk Gynekol; 1988 Mar; 53(3):228-32. PubMed ID: 3383267
[No Abstract] [Full Text] [Related]
26. Body composition, blood pressure, and lipid metabolism before and during long-term growth hormone (GH) treatment in children with short stature born small for gestational age either with or without GH deficiency.
Sas T; Mulder P; Hokken-Koelega A
J Clin Endocrinol Metab; 2000 Oct; 85(10):3786-92. PubMed ID: 11061539
[TBL] [Abstract][Full Text] [Related]
27. Growth hormone treatment of children with short stature secondary to intra-uterine growth retardation: effect of 2 years' treatment and 2 years' follow-up.
Rosilio M; Carel JC; Blazy D; Chaussain JL
Horm Res; 1997; 48 Suppl 4():23-8. PubMed ID: 9350442
[TBL] [Abstract][Full Text] [Related]
28. Early versus Late Enteral Feeding in Preterm Intrauterine Growth Restricted Neonates with Antenatal Doppler Abnormalities: An Open-Label Randomized Trial.
Tewari VV; Dubey SK; Kumar R; Vardhan S; Sreedhar CM; Gupta G
J Trop Pediatr; 2018 Feb; 64(1):4-14. PubMed ID: 28369652
[TBL] [Abstract][Full Text] [Related]
29. Renal drug clearance in preterm neonates: relation to prenatal growth.
Allegaert K; Anderson BJ; van den Anker JN; Vanhaesebrouck S; de Zegher F
Ther Drug Monit; 2007 Jun; 29(3):284-91. PubMed ID: 17529884
[TBL] [Abstract][Full Text] [Related]
30. [Active treatment of intrauterine fetal growth retardation].
Caspi B; Dolfin D; Katz Z; Mogilner M; Borenstein R; Lancet M
Harefuah; 1979 Feb; 96(3):144-6. PubMed ID: 488808
[No Abstract] [Full Text] [Related]
31. [Growth hormone treatment in secondary growth retardation].
de Muinck Keizer-Schrama SM
Tijdschr Kindergeneeskd; 1988 May; 56 Suppl 1():33-9. PubMed ID: 3046057
[No Abstract] [Full Text] [Related]
32. [Extrauterine growth retardation and correlated factors in premature neonates].
Shan HM; Cai W; Sun JH; Cao Y; Shi YY; Fang BH
Zhonghua Er Ke Za Zhi; 2007 Mar; 45(3):183-8. PubMed ID: 17504621
[TBL] [Abstract][Full Text] [Related]
33. Chemical changes in human skeletal muscle during fetal development.
Brans YW; Shannon DL
Biol Neonate; 1981; 40(1-2):21-8. PubMed ID: 7197167
[TBL] [Abstract][Full Text] [Related]
34. Congenital idiopathic growth hormone deficiency associated with prenatal and early postnatal growth failure. The International Board of the Kabi Pharmacia International Growth Study.
Gluckman PD; Gunn AJ; Wray A; Cutfield WS; Chatelain PG; Guilbaud O; Ambler GR; Wilton P; Albertsson-Wikland K
J Pediatr; 1992 Dec; 121(6):920-3. PubMed ID: 1447657
[TBL] [Abstract][Full Text] [Related]
35. Birth weight influences the initial response to growth hormone treatment in growth hormone-insufficient children.
Achermann JC; Hamdani K; Hindmarsh PC; Brook CG
Pediatrics; 1998 Aug; 102(2 Pt 1):342-5. PubMed ID: 9685436
[TBL] [Abstract][Full Text] [Related]
36. Growth hormone and body composition.
Christiansen JS
J Pediatr Endocrinol Metab; 1996 Jun; 9 Suppl 3():365-8. PubMed ID: 8887182
[TBL] [Abstract][Full Text] [Related]
37. A Neonate with Abnormal Upper Limbs and Exposed Bowel.
Riebe B; Pimpalwar A; Mahdi E; Vachharajani A
Neoreviews; 2020 Aug; 21(8):e587-e590. PubMed ID: 32737178
[No Abstract] [Full Text] [Related]
38. Neonatal management and long-term sequelae.
Halliday HL
Best Pract Res Clin Obstet Gynaecol; 2009 Dec; 23(6):871-80. PubMed ID: 19632899
[TBL] [Abstract][Full Text] [Related]
39. Metabolic implications of GH treatment in small for gestational age.
Delemarre EM; Rotteveel J; Delemarre-van de Waal HA
Eur J Endocrinol; 2007 Aug; 157 Suppl 1():S47-50. PubMed ID: 17785697
[TBL] [Abstract][Full Text] [Related]
40. Chronic pulsatile infusion of growth hormone to growth-restricted fetal sheep increases circulating fetal insulin-like growth factor-I levels but not fetal growth.
Bauer MK; Breier BB; Bloomfield FH; Jensen EC; Gluckman PD; Harding JE
J Endocrinol; 2003 Apr; 177(1):83-92. PubMed ID: 12697039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
